Eone Diagnomics Genome Center Co., Ltd. Logo

Eone Diagnomics Genome Center Co., Ltd.

A healthcare company specializing in genetic analysis for personalized medicine.

245620 | KO

Overview

Corporate Details

ISIN(s):
KR7245620000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 갯벌로 143 -, 인천광역시

Description

Eone Diagnomics Genome Center (EDGC) is a healthcare company specializing in genetic analysis services. Utilizing Next-Generation Sequencing (NGS) and advanced bioinformatics, the company provides a range of clinical and consumer genetic tests. Its services span the entire life cycle, from the NICE® non-invasive prenatal test for fetal chromosomal abnormalities to the bebegene® newborn genetic screening test. For adults, EDGC offers the MYGENPLAN® integrated genotype and phenotype test for personalized healthcare guidance and the gene2me® Plus test, which predicts genetic risk for major cancers and general diseases. The company focuses on delivering clinical solutions for precision and personalized medicine, enabling disease prevention and customized care based on individual genetic information.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-18 00:00
주권매매거래정지기간변경 (상장폐지 사유 발생)
Korean 5.0 KB
2024-04-18 00:00
기타시장안내 (상장폐지 관련 안내)
Korean 3.2 KB
2024-04-08 00:00
주권매매거래정지 (풍문 또는 보도 관련)
Korean 5.0 KB
2024-04-08 00:00
조회공시요구(풍문또는보도) (감사의견 비적정설)
Korean 3.3 KB
2024-04-08 00:00
감사보고서제출
Korean 25.7 KB
2024-04-08 00:00
주권매매거래정지기간변경 (투자자 보호)
Korean 5.4 KB
2024-04-08 00:00
사업보고서 (2023.12)
Korean 745.9 KB
2024-04-08 00:00
기타시장안내 (감사의견 거절 관련)
Korean 3.7 KB
2024-04-08 00:00
증권발행결과(자율공시)
Korean 7.3 KB
2024-04-08 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 32.2 KB
2024-04-08 00:00
[기재정정]증권발행결과(자율공시)
Korean 10.9 KB
2024-04-04 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.6 KB
2024-04-04 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 74.6 KB
2024-03-29 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.2 KB
2024-03-27 00:00
정기주주총회결과
Korean 18.4 KB

Automate Your Workflow. Get a real-time feed of all Eone Diagnomics Genome Center Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eone Diagnomics Genome Center Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eone Diagnomics Genome Center Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.